ABBOTT PRALIDOXIME IODIDE 500mg/20mL injection ampoule

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

pralidoxime iodide, Quantity: 25 mg/mL

Disponible depuis:

Phebra Pty Ltd

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: water for injections

Mode d'administration:

Intravenous, Intramuscular

Unités en paquet:

20mL x 1

Type d'ordonnance:

Not scheduled. Not considered by committee

indications thérapeutiques:

This product accepted for registration/listing as 'currently supplied' at the time of commencement of the Act. Indications held in ARTG paper records. (Old code) INDICATIONS AS AT 01 JAN 1991 : Pralidoxime Iodide injection is indicated as an antidote for : The treatment of poisoning due to those pesticides and chemicals of the organophosphate class which have anticholinesterase activity, and the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis.

Descriptif du produit:

Visual Identification: Clear, colourless to pale straw coloured solution.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Registered

Date de l'autorisation:

1991-10-21